A board to discuss future MS therapies in early stage (Phase I or II) trials.


Postby bromley » Wed Aug 10, 2005 4:06 am

Dear all,

Results from the Phase I / II Tovaxin trial are to be presented at the ACTRIMS / ECTRIMS conference at the end of September / early October 2005. Tim who is participating in the trial has posted his experience on this site - and has seen good results. Unlike the ABCRs this treatment does appear to improve EDSS ratings which, to me, is more important than relapse rates (although Tim has not experienced a relapse since starting on the trial in late 2003).


I contacted the company about participation in the phase IIb / III trial but was told that there were no plans at present for trials in the UK. Trials will be taking place in the US (maybe Canada?).
User avatar
Family Elder
Posts: 1887
Joined: Fri Sep 10, 2004 2:00 pm


Return to Drug Pipeline


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service